135.46
-3.14
(-2.27%)
At close: April 11 at 5:32:27 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 20 | 19 | 26 | 25 |
| Avg. Estimate | 19.84B | 20.66B | 85.18B | 98.69B |
| Low Estimate | 18.49B | 18.7B | 80.56B | 89.62B |
| High Estimate | 23.24B | 23.66B | 93.32B | 112.67B |
| Year Ago Sales | 16.57B | 16.87B | 66.52B | 85.18B |
| Sales Growth (year/est) | 19.77% | 22.51% | 28.05% | 15.87% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| BA.VI | -- | -- | -- | -- |
| S&P 500 | 6.43% | 6.13% | 9.43% | 14.26% |
Upgrades & Downgrades
| Maintains | Wells Fargo: Underweight to Underweight | 3/17/2025 |
| Maintains | Citigroup: Buy to Buy | 2/10/2025 |
| Maintains | JP Morgan: Overweight to Overweight | 1/29/2025 |
| Maintains | RBC Capital: Outperform to Outperform | 1/29/2025 |
| Maintains | Susquehanna: Positive to Positive | 1/29/2025 |
| Maintains | UBS: Buy to Buy | 1/29/2025 |